Pfizer’s Seagen bet sours further; China debate continues to heat up; and more

Welcome back to another edition of Endpoints Weekly. My usual colleague Nicole DeFeudis is out this week, so I’ve assembled the Weekly with the help of Lei Lei Wu! Let’s ...

Raccontata daendpoints.news